Masanobu Takahashi

机构：Yamagata University, Shibaura Institute of Technology, Tohoku University, Hokkaido University, Tohoku University Hospital, Yamagata University Hospital · ORCID：0000-0001-9306-7041

发表论文 359 篇 · 总被引 9271 次 · h-index 33

代表论文

• First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048 (2024 · International Journal of Clinical Oncology · 被引 10)
• Pretreatment neutrophil–lymphocyte ratio as a prognostic factor in recurrent/metastatic head and neck cancer treated with pembrolizumab (2024 · Scientific Reports · 被引 9)
• Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial (2026 · Nature Medicine · 被引 7)
• Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAFV600E colorectal cancer (2024 · Cancer Science · 被引 5)
• Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907) (2025 · European Journal of Cancer · 被引 4)
• Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan (2025 · Journal of Human Genetics · 被引 4)